U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H15NO2.BrH
Molecular Weight 262.144
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DMPEA HYDROBROMIDE

SMILES

Br.COC1=C(OC)C=C(CCN)C=C1

InChI

InChIKey=HKJSUKPBCYPOJO-UHFFFAOYSA-N
InChI=1S/C10H15NO2.BrH/c1-12-9-4-3-8(5-6-11)7-10(9)13-2;/h3-4,7H,5-6,11H2,1-2H3;1H

HIDE SMILES / InChI
Homoveratrylamine (3,4-dimethoxyphenethylamine, DMPEA) is an analog of the major neurotransmitter dopamine where 3- and 4- position hydroxyl groups are replaced with methoxy groups. DMPEA is a metabolite of dopamine and is reported to be produced at elevated levels in patients with schizophrenia and Parkinson's disease. DMPEA inhibited monoamine oxidase and demonstrated no peripheral and central antidopaminergic activity in vivo.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Fine structural specificity differences of trimethoprim allergenic determinants.
1996 Oct
Contribution of aldehyde oxidizing enzymes on the metabolism of 3,4-dimethoxy-2-phenylethylamine to 3,4-dimethoxyphenylacetic acid by guinea pig liver slices.
2006
4-[2-(3,4-Dimethoxy-phenethyl-amino)prop-oxy]-2-methoxy-benzamide.
2008 May 24
Self-assembly of 3,5-bis(ethoxycarbonyl)pyrazolate anions and ammonium cations of beta-phenylethylamine or homoveratrylamine into hetero-double-stranded helical structures.
2009 Aug 21
Enhancement of 5-aminopenta-2,4-dienals electrophilicity via activation by O,N-bistrifluoroacetylation. application to an N-acyl Pictet-Spengler reaction.
2009 Dec 18
Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases).
2009 Mar
Patents

Sample Use Guides

In Vivo Use Guide
In vivo experiments with DMPEA were performed on mice. Compound was administered intraperitoneally at doses 25-200 mg/kg.
Route of Administration: Intraperitoneal
Brain mitochondria, containing monoamine oxidase, were prepared from Wistar female rats. Monoamine oxidase activity was determined in the presence and absence of the DMPEA by manometric technique. The main compartment of Warburg flasks contained 0.8 ml of a 0.1 M buffered solution of the homoveratrylamine, 1 ml of mitochondrial suspension (representing 500 mg wet weight of original brain tissue), and sufficient 0.01 M phosphate buffer (pH 7.4) to make a total volume of 2.7 ml. All aliquots for a given run were taken from the same mitochondrial preparation. The side arm of each flask contained 0.3 ml of 0.1 M tyramine or tryptamine hydrochloride. After the flasks were allowed to equilibrate for 15 min at 37°, the manometer valves were closed and the side arm contents of each were tipped in. Manometers were set at 150 mm, and readings were taken at 15-min intervals for 90 min. Values for the 90-min reaction period were obtained for each flask and were multiplied by the respective flask constants after adjusting for changes in the thermobarometer. The total microliters of oxygen uptake for each flask was thus obtained.
Name Type Language
DMPEA HYDROBROMIDE
Common Name English
3,4-Dimethoxy-phenethylamine hydrobromide
Systematic Name English
Homoveratrylamine hydrobromide
Common Name English
Benzeneethanamine, 3,4-dimethoxy-, hydrobromide (1:1)
Systematic Name English
Code System Code Type Description
CAS
54373-56-7
Created by admin on Sat Dec 16 19:18:56 GMT 2023 , Edited by admin on Sat Dec 16 19:18:56 GMT 2023
PRIMARY
FDA UNII
ZZB3NR8KVD
Created by admin on Sat Dec 16 19:18:56 GMT 2023 , Edited by admin on Sat Dec 16 19:18:56 GMT 2023
PRIMARY
PUBCHEM
20337306
Created by admin on Sat Dec 16 19:18:56 GMT 2023 , Edited by admin on Sat Dec 16 19:18:56 GMT 2023
PRIMARY